Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

CSE/BIOV stock hub

CSE/BIOV has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CSE/BIOVis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.1M

Canadian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

CSE/BIOV

In the news

Latest news · CSE/BIOV

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/En/a

P25 7.4P50 15.6P75 34.3

ROEn/a

P25 -121.5P50 -40.9P75 0.5

ROICn/a

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CSE/BIOV market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

130

Groups with data

Currency

CAD

Showing 130 of 130 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Enterprise value	CAD 3.2M
Exchange	Canadian Securities Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Biotechnology
Isin	CA09076M2004
Last refreshed	2026-05-10
Market cap	CAD 3.1M
Price	CAD 0.07
Price currency	CAD
Sector	Healthcare
Sic	2834
Symbol	cse/BIOV
Website	https://biovaxys.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-193.41%
EV Earnings	-0.54x
P/B ratio	-0.85x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	CAD -6M
Net Income Growth Quarters	1%
Net Income Growth Years	2%
ROA	-152.8
Roa5y	-136.9
ROCE	127.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-76.69%
Cagr3y	-44.06%
Cagr5y	-54.01%
EPS Growth Quarters	1
EPS Growth Years	2
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	CAD 1.4M
Cash	CAD 4,080
Current Assets	CAD 1.4M
Current Liabilities	CAD 5M
Debt	CAD 133,720
Equity	CAD -3.6M
Liabilities	CAD 5M
Long Term Assets	CAD 0
Long Term Liabilities	CAD 0
Net Cash	CAD -129,640
Net Cash By Market Cap	CAD -4.2
Tangible Book Value	CAD -3.6M
Tangible Book Value Per Share	CAD -0.12
WACC	9.42

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.28
Net Working Capital	CAD -3.5M
Quick ratio	0.1
Working Capital	CAD -3.6M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-61.26%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-76.67%
200-day SMA	0.2
3Y total return	-82.5%
50-day SMA	0.08
50-day SMA vs 200-day SMA	50under200
5Y total return	-97.94%
All Time High	7.8
All Time High Change	-99.1%
All Time High Date	2021-02-16
All Time Low	0.03
All Time Low Change	133.33%
All Time Low Date	2026-04-13
ATR	0.01
Beta	1.01
Beta1y	2.26
Beta2y	0.91
Ch YTD	-68.18
High	0.07
High52	0.4
High52 Date	2025-08-27
High52ch	-82.5%
Low	0.07
Low52	0.03
Low52 Date	2026-04-13
Low52ch	133.33%
Ma50ch	-16.57%
Price vs 200-day SMA	-65.82%
RSI	52.82
RSI Monthly	34.55
RSI Weekly	35.1
Sharpe ratio	-0.23x
Sortino ratio	-0.3
Total Return	-61.26%
Tr YTD	-68.18
Tr1m	7.69%
Tr1w	16.67%
Tr3m	-57.58%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD -4.6M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	39,531,396%
Net Borrowing	-47,254
Shares Insiders	10.35%
Shares Out	44,094,671
Shares Qo Q	1.14%
Shares Yo Y	61.26%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	301,698x
Bv Per Share	-0.12
Ch1m	7.69
Ch1w	16.67
Ch1y	-76.67
Ch3m	-57.58
Ch3y	-82.5
Ch5y	-97.94
Ch6m	-69.57
Change	16.67%
Change From Open	0
Close	0.06
Days Gap	16.67
Dollar Volume	942.9
Earnings Date	2026-04-02
EBIT	CAD -4.6M
EPS	CAD -0.22
F Score	1
Financing CF	2,483,685
Fiscal Year End	October
Is Primary Listing	1
Last Earnings Date	2026-03-03
Last Report Date	2025-07-31
Last Split Date	2025-09-11
Last Split Type	Reverse
Ma150	0.18
Ma150ch	-61.39%
Ma20	0.06
Ma20ch	25%
Net CF	-486,765
Open	0.07
Price Date	2026-05-05
Relative Volume	0.04x
Share Based Comp	329,978
Tr6m	-69.57%
Volume	13,470

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CSE/BIOV pay a dividend?

Capital-return profile for this ticker.

Performance

CSE/BIOV stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CSE/BIOV?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+10.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+61.3%

Negative means the company is buying back shares.

Technical

CSE/BIOV momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

52.8

Neutral momentum band

Price vs 200-day MA

-65.8%

50/200-day relationship not available

Beta (5Y)

1.01

Moves roughly with the market

Sharpe ratio

-0.23

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CSE/BIOV

Hub-level FAQ points readers to the deeper analysis pages.

What is the current cse/BIOV stock rating?

cse/BIOV is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full cse/BIOV analysis?

The full report lives at /stocks/cse/BIOV/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for cse/BIOV?

The latest report frames cse/BIOV around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the cse/BIOV page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.